http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3256065

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 183
issn 1084-9785
1557-8852
issueIdentifier 5
pageRange 176-183
publicationName Cancer Biotherapy and Radiopharmaceuticals
startingPage 176
bibliographicCitation Yi H, Ye X, Long B, Ye T, Zhang L, Yan F, Yang Y, Li L. Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer. Cancer Biotherapy and Radiopharmaceuticals. 2017 Jun;32(5):176–83. doi: 10.1089/cbr.2017.2187.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af4c4599f7d60c28f4143325c1cebae5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_506cf85e28e716f0b378811b93b00ed4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2fc56df564f4a41a36a7cf8ffb16819c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5776ff35cfcd345d3d8fc74c4537190a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3262d0de9fc3b4bf220127549351daf6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f4fda48e7d58ed977b386db3660297f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8718ffd7f994cac5ccad27e5d305e76
date 201706
identifier https://doi.org/10.1089/cbr.2017.2187
https://pubmed.ncbi.nlm.nih.gov/28622037
isPartOf https://portal.issn.org/resource/ISSN/1084-9785
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21658
https://portal.issn.org/resource/ISSN/1557-8852
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer
discusses http://id.nlm.nih.gov/mesh/M0543256
http://id.nlm.nih.gov/mesh/M0446095
http://id.nlm.nih.gov/mesh/M0014833
http://id.nlm.nih.gov/mesh/M0469193
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0150739
http://id.nlm.nih.gov/mesh/M0016578
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D013964Q000178
http://id.nlm.nih.gov/mesh/D010671Q000627
http://id.nlm.nih.gov/mesh/D058570Q000037
http://id.nlm.nih.gov/mesh/D009536Q000031
http://id.nlm.nih.gov/mesh/D051057Q000037
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D018572
http://id.nlm.nih.gov/mesh/D000077157
http://id.nlm.nih.gov/mesh/D013964Q000473
http://id.nlm.nih.gov/mesh/D010671Q000008
http://id.nlm.nih.gov/mesh/D010671Q000494
http://id.nlm.nih.gov/mesh/D009536Q000494
http://id.nlm.nih.gov/mesh/D049109
http://id.nlm.nih.gov/mesh/D009536Q000627
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D009536Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11977753
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9419

Total number of triples: 61.